|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
19 February 2015 |
|
Main ID: |
NCT02209675 |
|
Date of registration:
|
31/07/2014 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Role of Tissue C4d in Differentiation Between Acut e Rejection and HCV Recurrence After Liver Transplantation
|
|
Scientific title:
|
|
|
Date of first enrolment:
|
December 2012 |
|
Target sample size:
|
25 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT02209675 |
|
Study type:
|
Interventional |
|
Study design:
|
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Egypt
| | | | | | | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Patients transplanted for HCV related disease that are presented with elevated liver
enzyme and/or hyperbilirubinemia and normal Abdominal Doppler ultrasound and
Magnetic resonance cholangiography (MRCP).
Exclusion Criteria:
- Evidence of other causes of elevated liver enzyme and/or hyperbilirubinemia as
abnormal Abdominal Doppler ultrasound and/or Magnetic resonance cholangiography
MRCP findings.
Age minimum:
18 Years
Age maximum:
65 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Liver Disease
|
|
Intervention(s)
|
|
Other: liver biopsy
|
|
Primary Outcome(s)
|
|
Number of participants who developed Acute cellular rejection after transplantation
[Time Frame: 2 years]
|
|
Secondary ID(s)
|
|
tissue C4d
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|